Physician profile
Eric A Kovan
NPI 1619965159
$6,949.06
in general payments reported to CMS, 2019-2025
51 companies · $576 in 2025
The $576 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $1,028 · 2021: $1,208 · 2022: $730 · 2023: $809 · 2024: $1,408 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,792.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $969.90 | 2021-2025 | |
| Medtronic, INC. | $818.08 | 2023-2025 | Intellis Adaptivestim, Activos 10 Bone Cement |
| Scilex Pharmaceuticals INC. | $722.34 | 2019-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $507.03 | 2019-2024 | Belbuca, Xtampza |
| Allergan, INC. | $380.23 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $348.36 | 2019-2025 | Austedo Xr, Austedo Xr |
| Boston Scientific Corporation | $274.81 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Mdd US Operations, LLC | $272.05 | 2019-2020 | |
| Amgen INC. | $266.03 | 2019-2022 | |
| Pacira Therapeutics, INC. | $240.34 | 2019-2021 | |
| Abbott Laboratories | $166.36 | 2019-2022 | |
| Almatica Pharma LLC | $152.93 | 2020-2023 | Gralise |
| Pfizer INC. | $137.16 | 2019-2025 | |
| Merz Pharmaceuticals, LLC | $123.15 | 2023-2025 | Xeomin |
| Surgalign Spine Technologies, INC. | $105.62 | 2020 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.